
Ron Finklestien
Uncovering the Truth: Rivian Automotive (RIVN) Evaluation Based on Wall Street’s Optimistic Perceptions
Investors often lean on analyst recommendations to inform their decisions about stocks. Reports about rating changes by these brokerage-firm-employed (or sell-side) analysts can significantly ...
NXP Semiconductors Drives Automotive Innovation With SAF86xx
NXP Semiconductors Drives Automotive Innovation With SAF86xx
NXP Semiconductors N.V. NXPI is reaping the rewards of a robust product portfolio and an expanding customer base. Notably, its shares have surged 23.1% ...
TH International’s Expansion in China
TH International Sees Growth in Store Openings
Key Takeaways from Expansion TH International has recorded its strongest-ever growth for new store openings in the last year’s fourth quarter, with a total ...
The Turbulent Skies: Delta Air Lines’ Q4 Results Send Shockwaves Through the Market
U.S. stocks traded mostly lower, with the Dow Jones index falling around 150 points on Friday. Shares of Delta Air Lines, Inc. DAL took ...
US House China Panel Summons Intel, Nvidia, and Micron CEOs for Testimony
US House China Panel Summons Intel, Nvidia, and Micron CEOs for Testimony
tzahiV Scrutiny of US Chip Manufacturers The House of Representatives’ China panel is summoning the chief executives of major U.S. chip manufacturers in an ...
Infosys Stuns Market with Q3 Performance
Infosys Stuns Market with Q3 Performance
Infosys Limited INFY shares set the stock market abuzz on Thursday, galloping 4% higher after the India-based IT consulting and outsourcing company unfurled a ...
US Stocks Rise on Producer Price Deflation
US Stocks Rise on Producer Price Deflation
U.S. stocks took a positive turn this morning, reflecting the release of producer price index (PPI) data on Friday. Leading and Lagging Sectors Energy ...
Key Moves in Pharma: MRK to Buy Harpoon, JNJ to Acquire Ambrx Biopharma & More
Pharma Stock Roundup: Merck’s Acquisition of Harpoon and JNJ’s Purchase of Ambrx
This week, both Merck MRK and J&J JNJ announced plans to acquire cancer biotechs making oncology therapies with novel mechanisms of action. AbbVie ABBV ...















